Tryptophan and tyrosine availability and response to antidepressant treatment in major depression.
暂无分享,去创建一个
[1] A. Young,et al. Corticosteroid-serotonin interactions in depression: a review of the human evidence , 2004, Psychopharmacology.
[2] P. Joyce,et al. A differential response to nortriptyline and fluoxetine in melancholic depression: the importance of age and gender , 2003, Acta psychiatrica Scandinavica.
[3] T. Suslow,et al. Oral citalopram and reboxetine challenge tests before and after selective antidepressant treatment. , 2003, Journal of psychiatric research.
[4] P. Cowen,et al. Contrasting effects of citalopram and reboxetine on waking salivary cortisol , 2003, Psychopharmacology.
[5] P. Sullivan,et al. Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline. , 2001, The Australian and New Zealand journal of psychiatry.
[6] P. Cowen,et al. Impaired regulation of brain serotonin function during dieting in women recovered from depression , 2000, British Journal of Psychiatry.
[7] C. McDougle,et al. Tryptophan Depletion During Continuous CSF Sampling in Healthy Human Subjects , 1998, Neuropsychopharmacology.
[8] R. Golden,et al. Psychoneuroendocrinology of depression. Prolactin. , 1998, The Psychiatric clinics of North America.
[9] C. McDougle,et al. The Neurobiology of Tryptophan Depletion in Depression: Effects of Intravenous Tryptophan Infusion , 1998, Biological Psychiatry.
[10] M Diksic,et al. Differences between males and females in rates of serotonin synthesis in human brain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[11] S. Møller. Plasma amino acid profiles in relation to clinical response to moclobemide in patients with major depression , 1993 .
[12] M. First,et al. The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. , 1992, Archives of general psychiatry.
[13] S. Møller,et al. Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements , 1991, Acta psychiatrica Scandinavica.
[14] S. Møller,et al. Plasma tyrosine/neutral amino acid ratio correlated with clinical response to nortriptyline in endogenously depressed patients. , 1985, Journal of affective disorders.
[15] T. Tanaka,et al. A new glucocorticoid receptor species: relation to induction of tryptophan dioxygenase by glucocorticoids. , 1985, Endocrinology.
[16] S. Møller. Tryptophan to competing amino acids ratio in depressive disorder: relation to efficacy of antidepressive treatments , 1985, Acta psychiatrica Scandinavica. Supplementum.
[17] P. Elder,et al. An enzyme-linked immunosorbent assay (ELISA) for plasma testosterone. , 1985, Journal of steroid biochemistry.
[18] S. Møller. Quantitative determination of branched-chain and aromatic amino acids by ion-exchange chromatography. , 1977, Analytical biochemistry.
[19] W. H. Warren,et al. Error in the determination of tryptophan by the method of Denkla and Dewey. A revised procedure. , 1974, Analytical biochemistry.
[20] R. Wurtman,et al. Brain Serotonin Content: Physiological Dependence on Plasma Tryptophan Levels , 1971, Science.
[21] S. Møller,et al. Plasma tryptophan and tyrosine ratios to competing amino acids in relation to antidepressant response to citalopram and maprotiline , 2004, Psychopharmacology.
[22] R. Porter,et al. Baseline prolactin and L-tryptophan availability predict response to antidepressant treatment in major depression , 2002, Psychopharmacology.
[23] E. Smeraldi,et al. Plasma tryptophan to large neutral amino acids ratio and therapeutic response to a selective serotonin uptake inhibitor. , 1994, Neuropsychobiology.
[24] P. Bech,et al. Plasma ratio trytophan/neutral amino acids in relation to clinical response to paroxetine and clomipramine in patients with major depression , 1990 .
[25] M. Candito,et al. Diurnal variation in total plasma tryptophan in controls and in depression. , 1990, Journal of psychiatric research.